• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

解决STODS——手术性暂时性眼部不适综合征

Solving STODS-Surgical Temporary Ocular Discomfort Syndrome.

作者信息

Hirabayashi Matthew T, Barnett Brad P

机构信息

Department of Ophthalmology, University of Missouri School of Medicine, 1 Hospital Dr, Columbia, MO 65212, USA.

California LASIK & Eye, 1111 Exposition Blvd. Bldg. 200, Ste. 2000, Sacramento, CA 95815, USA.

出版信息

Diagnostics (Basel). 2023 Feb 22;13(5):837. doi: 10.3390/diagnostics13050837.

DOI:10.3390/diagnostics13050837
PMID:36899981
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10000827/
Abstract

The term STODS (Surgical Temporary Ocular Discomfort Syndrome) has been coined to describe the ocular surface perturbations induced by surgery. As one of the most important refractive elements of the eye, Guided Ocular Surface and Lid Disease (GOLD) optimization is fundamental to success in achieving refractive outcomes and mitigating STODS. Effective GOLD optimization and the prevention/treatment of STODS requires an understanding of the molecular, cellular, and anatomic factors that influence ocular surface microenvironment and the associated perturbations induced by surgical intervention. By reviewing the current understanding of STODS etiologies, we will attempt to outline a rationale for a tailored GOLD optimization depending on the ocular surgical insult. With a bench-to-bedside approach, we will highlight clinical examples of effective GOLD perioperative optimization that can mitigate STODS' deleterious effect on preoperative imaging and postoperative healing.

摘要

“手术性暂时性眼不适综合征”(STODS)这一术语已被创造出来,用于描述手术引起的眼表扰动。作为眼睛最重要的屈光元件之一,引导性眼表和眼睑疾病(GOLD)优化对于实现屈光手术效果和减轻STODS至关重要。有效的GOLD优化以及STODS的预防/治疗需要了解影响眼表微环境的分子、细胞和解剖学因素,以及手术干预引起的相关扰动。通过回顾目前对STODS病因的认识,我们将尝试概述根据眼部手术损伤进行定制化GOLD优化的基本原理。采用从 bench 到 bedside 的方法,我们将重点介绍有效的GOLD围手术期优化的临床实例,这些实例可以减轻STODS对术前成像和术后愈合的有害影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61a9/10000827/4e74ae118277/diagnostics-13-00837-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61a9/10000827/50f67ebc4d1f/diagnostics-13-00837-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61a9/10000827/77e877e8499d/diagnostics-13-00837-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61a9/10000827/d73999b26476/diagnostics-13-00837-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61a9/10000827/2ac83e17435c/diagnostics-13-00837-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61a9/10000827/cfdd555be935/diagnostics-13-00837-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61a9/10000827/f994c29ce2fa/diagnostics-13-00837-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61a9/10000827/ec037ab4b54a/diagnostics-13-00837-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61a9/10000827/4e74ae118277/diagnostics-13-00837-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61a9/10000827/50f67ebc4d1f/diagnostics-13-00837-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61a9/10000827/77e877e8499d/diagnostics-13-00837-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61a9/10000827/d73999b26476/diagnostics-13-00837-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61a9/10000827/2ac83e17435c/diagnostics-13-00837-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61a9/10000827/cfdd555be935/diagnostics-13-00837-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61a9/10000827/f994c29ce2fa/diagnostics-13-00837-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61a9/10000827/ec037ab4b54a/diagnostics-13-00837-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61a9/10000827/4e74ae118277/diagnostics-13-00837-g008.jpg

相似文献

1
Solving STODS-Surgical Temporary Ocular Discomfort Syndrome.解决STODS——手术性暂时性眼部不适综合征
Diagnostics (Basel). 2023 Feb 22;13(5):837. doi: 10.3390/diagnostics13050837.
2
Dry eye disease after refractive surgery: comparative outcomes of small incision lenticule extraction versus LASIK.屈光手术后干眼:微切口晶状体提取术与 LASIK 的对比结果。
Ophthalmology. 2015 Apr;122(4):669-76. doi: 10.1016/j.ophtha.2014.10.004. Epub 2014 Nov 22.
3
Comparison of visual and refractive outcomes following femtosecond laser- assisted lasik with smile in patients with myopia or myopic astigmatism.飞秒激光辅助 LASIK 联合 Smile 手术治疗近视或近视散光患者的视力和屈光效果比较。
J Refract Surg. 2014 Sep;30(9):590-6. doi: 10.3928/1081597X-20140814-02.
4
Short-Term Impact of FS-LASIK and SMILE on Dry Eye Metrics and Corneal Nerve Morphology.FS-LASIK 和 SMILE 对干眼指标和角膜神经形态的短期影响。
Cornea. 2020 Jul;39(7):851-857. doi: 10.1097/ICO.0000000000002312.
5
Ocular surface diseases and corneal refractive surgery.眼表疾病与角膜屈光手术。
Curr Opin Ophthalmol. 2014 Jul;25(4):264-9. doi: 10.1097/ICU.0000000000000077.
6
Dry Eye After LASIK.LASIK 术后干眼
Invest Ophthalmol Vis Sci. 2018 Nov 1;59(14):DES109-DES115. doi: 10.1167/iovs.17-23538.
7
Small incision lenticule extraction (SMILE) versus laser in-situ keratomileusis (LASIK): study protocol for a randomized, non-inferiority trial.小切口微透镜取出术(SMILE)与激光原位角膜磨镶术(LASIK)的比较:一项随机、非劣效性试验的研究方案。
Trials. 2012 May 31;13:75. doi: 10.1186/1745-6215-13-75.
8
Management of the ocular surface and tear film before, during, and after laser in situ keratomileusis.准分子原位角膜磨镶术术前、术中及术后眼表和泪膜的管理
J Refract Surg. 2004 Jan-Feb;20(1):62-71. doi: 10.3928/1081-597X-20040101-11.
9
Three-year results of small incision lenticule extraction and wavefront-guided femtosecond laser-assisted laser keratomileusis for correction of high myopia and myopic astigmatism.小切口透镜切除术与波前引导飞秒激光原位角膜磨镶术矫正高度近视和近视散光的三年结果
Int J Ophthalmol. 2018 Mar 18;11(3):470-477. doi: 10.18240/ijo.2018.03.18. eCollection 2018.
10
Ocular Surface Changes Associated with Ophthalmic Surgery.与眼科手术相关的眼表变化
J Clin Med. 2021 Apr 12;10(8):1642. doi: 10.3390/jcm10081642.

引用本文的文献

1
Preventing and Managing Iatrogenic Dry Eye Disease during the Entire Surgical Pathway: A Study Focusing on Patients Undergoing Cataract Surgery.在整个手术过程中预防和管理医源性干眼疾病:一项针对白内障手术患者的研究
J Clin Med. 2024 Jan 27;13(3):748. doi: 10.3390/jcm13030748.

本文引用的文献

1
Cell-Free Amniotic Fluid and Regenerative Medicine: Current Applications and Future Opportunities.无细胞羊水与再生医学:当前应用与未来机遇
Biomedicines. 2022 Nov 17;10(11):2960. doi: 10.3390/biomedicines10112960.
2
Understanding and Optimizing Ocular Biometry for Cataract Surgery in Dry Eye Disease: A Review.理解和优化干眼疾病白内障手术中的眼生物测量:综述。
Semin Ophthalmol. 2023 Jan;38(1):24-30. doi: 10.1080/08820538.2022.2112699. Epub 2022 Aug 20.
3
Lotilaner Ophthalmic Solution, 0.25%, for the Treatment of Demodex Blepharitis: Results of a Prospective, Randomized, Vehicle-Controlled, Double-Masked, Pivotal Trial (Saturn-1).
Lotilaner 眼科溶液,0.25%,用于治疗蠕形螨睑缘炎:一项前瞻性、随机、对照、双盲、关键试验(Saturn-1)的结果。
Cornea. 2023 Apr 1;42(4):435-443. doi: 10.1097/ICO.0000000000003097. Epub 2022 Aug 10.
4
Pathophysiology of dry eye disease and novel therapeutic targets.干眼疾病的病理生理学及新型治疗靶点
Exp Eye Res. 2022 Apr;217:108944. doi: 10.1016/j.exer.2022.108944. Epub 2022 Jan 22.
5
Hypochlorous Acid Can Be the Novel Option for the Meibomian Gland Dysfunction Dry Eye through Ultrasonic Atomization.次氯酸通过超声雾化可成为治疗睑板腺功能障碍性干眼症的新选择。
Dis Markers. 2022 Jan 5;2022:8631038. doi: 10.1155/2022/8631038. eCollection 2022.
6
Efficacy and Safety of OC-01 (Varenicline Solution) Nasal Spray on Signs and Symptoms of Dry Eye Disease: The ONSET-2 Phase 3 Randomized Trial.OC-01(伐尼克兰溶液)鼻喷雾剂治疗干眼病体征和症状的疗效与安全性:ONSET-2 3期随机试验
Ophthalmology. 2022 Apr;129(4):379-387. doi: 10.1016/j.ophtha.2021.11.004. Epub 2021 Nov 10.
7
Lyophilized amniotic membrane graft for primary pterygium surgery: preliminary results.冻干羊膜移植在原发性翼状胬肉手术中的应用:初步结果。
Cell Tissue Bank. 2022 Jun;23(2):401-406. doi: 10.1007/s10561-021-09955-3. Epub 2021 Oct 10.
8
The Effectiveness and Safety of Dextenza 0.4 mg for the Treatment of Postoperative Inflammation and Pain in Patients After Photorefractive Keratectomy: The RESTORE Trial.地夸磷索钠 0.4mg 治疗准分子激光角膜切削术后炎症和疼痛的有效性和安全性:RESTORE 试验。
J Refract Surg. 2021 Sep;37(9):590-594. doi: 10.3928/1081597X-20210610-05. Epub 2021 Sep 1.
9
Cataract Surgery by Intraoperative Surface Irrigation with 0.25% Povidone-Iodine.术中使用0.25%聚维酮碘进行表面冲洗的白内障手术。
J Clin Med. 2021 Aug 16;10(16):3611. doi: 10.3390/jcm10163611.
10
Real-World Experience with Lifitegrast Ophthalmic Solution (Xiidra) in the US and Canada: Retrospective Study of Patient Characteristics, Treatment Patterns, and Clinical Effectiveness in 600 Patients with Dry Eye Disease.在美国和加拿大使用lifitegrast眼药水(Xiidra)的真实世界经验:对600例干眼病患者的患者特征、治疗模式及临床疗效的回顾性研究
Clin Ophthalmol. 2021 Mar 8;15:1041-1054. doi: 10.2147/OPTH.S296510. eCollection 2021.